Dermatophagoides pteronyssinus

FDA Drug Profile — Standardized Mite Dermatophagoides pteronyssinus

Dermatophagoides pteronyssinus is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Standardized Mite Dermatophagoides pteronyssinus. Available dosage form: concentrate.

Drug details

Generic Name
Dermatophagoides pteronyssinus
Brand Names
Standardized Mite Dermatophagoides pteronyssinus
Application Number
BLA101835
Sponsor
Greer Laboratories, Inc.
NDC Codes
3
Dosage Forms
CONCENTRATE
Routes
INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
Active Ingredients
DERMATOPHAGOIDES PTERONYSSINUS

Indications and Usage

1 INDICATIONS AND USAGE Greer Standardized Mite ( Dermatophagoides farinae and/or Dermatophagoides pteronyssinus ) Extracts are allergenic extracts indicated for: skin test diagnosis of mite allergy treatment of patients with mite-induced allergic asthma, rhinitis and conjunctivitis. For immunotherapy, patients must show hypersensitivity to Dermatophagoides farinae ( D. farinae ) or Dermatophagoides pteronyssinus ( D. pteronyssinus ) based on their clinical history, allergen exposure history, and skin test reactivity. Greer Standardized Mite Extracts are allergenic extracts indicated for: Diagnosis of skin test reactivity to dust mite allergen (1) Treatment of mite-induced allergic asthma, rhinitis and conjunctivitis in patients that show hypersensitivity to dust mites based on clinical history, allergen exposure history, and skin test reactivity (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.